European Archives - Page 417 of 1104 - European Medical Journal

Sales reps, MSLs and the future of CX

In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.

Is the generics and biosimilars sector at risk of collapse?

Generics and biosimilars are crucial to healthcare worldwide, but there are challenges in getting these medicine to patients.

Interview: Christopher Chapple

EMJ spoke to Christopher Chapple about his role as Secretary General of the European Association of Urology (EAU)…

Confronting health inequities for transgender patients

The challenges faced by the transgender community are vast, but pharma has the power to drive better health equity. Read more.

EMJ

Infographic: Boehringer Ingelheim | Improve, Protect, Prevent

Infographic: Boehringer Ingelheim | Improve, Protect, Prevent. The publication of this infographic has been funded by Boehringer Ingelheim.

The Importance of Ultrasound in Rheumatology

This Podcast, hosted by Brigitte Scott, explores the important role ultrasound has in Rheumatology. Join experts Lene Terslev, Chief Consultant in Rheumatology at Rigshospitalet, and Professor of Rheumatology at Copenhagen University, Denmark, and Esperanza Naredo, Rheumatologist and Associate Professor at Universidad Autónoma de Madrid, Spain…

Stories from the Operating Theatre

Ariel Halevy joins Jonathan to look back on his career as a general surgeon, sharing stories from the operating theatre.

ECTRIMS Feature

EMJ Neurology 10 [Supplement 2] 2022

Welcome to the EMJ review of the 38th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022 Congress, which took place in Amsterdam, the Netherlands, on 26th–28th October. This review showcases key abstract presentations, including an analysis on the value of serum neurofilament light chain in predicting multiple sclerosis diagnosis and future disability.

Addressing Global Cancer Care Inequities

Implementation science and community-engaged approaches can address cancer inequities by improving the delivery, uptake, and effective expansion of evidence-based cancer care in real-world resource-limited settings.

ECTRIMS Feature

Review of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2022

THIS YEAR’S European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress was the 38th, and the first ever hybrid congress organised by ECTRIMS. The congress, which is the world’s largest for research into the pathogenesis, diagnosis, and treatment in multiple sclerosis (MS) and related neurological disorders, is held in collaboration with Rehabilitation in Multiple Sclerosis (RIMS).